Patterns of practice in the radiation therapy management of rectal cancer: Survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "associazione Italiana di Radioterapia Oncologica (AIRO)"

Tumori

Volumn 99, Issue 1, 2013, Pages 61-67

  Di Genesio Pagliuca, Milena ^a   Turri, Lucia ^a   Munoz, Fernando ^b   Melano, Antonella ^c   Bacigalupo, Almalina ^d   Franzone, Paola ^e   Sciacero, Piera ^f   Tseroni, Vassiliki ^b   Vitali, Maria Laura ^g   Delmastro, Elena ^h   Scolaro, Tindaro ⁱ   Marziano, Corrado ^j   Orsatti, Marco ^k   Tessa, Maria ^l   Rossi, Annalisa ^m   Ballarè, Andrea ⁿ   Moro, Gregorio ^o   Grasso, Rachele ^a   Krengli, Marco ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e SS Antonio e Biagio General Hospital   (Italy)

^f Ivrea Community Hospital   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h CANDIOLO CANCER INSTITUTE   (Italy)

ⁱ Felettino Hospital   (Italy)

^j Department of Internal Medicine   (Italy)

^k Sanremo Hospital   (Italy)

^l CARDINAL MASSAIA HOSPITAL   (Italy)

^m MAURIZIANO HOSPITAL   (Italy)

ⁿ Castelli Hospital   (Italy)

^o OSPEDALE DEGLI INFERMI   (Italy)

more..

Author keywords

Management; Rectal cancer; Survey

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM COMPLEX;

ABDOMINAL RADIOGRAPHY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; ITALY; LONG COURSE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS RADIOGRAPHY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION INJURY; RECTUM CANCER; SHORT COURSE THERAPY; THORAX RADIOGRAPHY; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; HEALTH CARE QUALITY; HEALTH CARE SURVEY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; ONCOLOGY; PALLIATIVE THERAPY; PATHOLOGY; PATIENT CARE; RADIATION DOSE FRACTIONATION; RECTUM TUMOR; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; COLONOSCOPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ENDOSONOGRAPHY; FEMALE; FLUOROURACIL; HEALTH CARE SURVEYS; HUMANS; ITALY; LEUCOVORIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PALLIATIVE CARE; PATIENT CARE TEAM; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; QUALITY ASSURANCE, HEALTH CARE; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84878139589     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1248.13790     Document Type: Article

References (34)

1. Zhi-Hui C, Xin-Ming S, Shi-Cai C, Ming-Zhe L, Xin-Xin L, Wen-Hua Z, Yu-Long H: Risk factors and adverse out come in low rectal cancer: World J Gastoenterol, 18: 64-69, 2012.
2. I Tumori in Italia. Portale di epidemiologia oncologica. Available at http://www.tumori.net/it
3. I tumori in Piemonte, aspetti epidemiologici. Rapporto 2011. Regione Piemonte Assessorato Tutela della Salute e Sanità -Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte. Maggio 2011. Available at www.cpo.it
4. Baxter NN, Garcia-Agiular J: Organ preservation for rectal cancer. J Clin Oncol, 25: 1014-1020, 2007.
5. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group: Dutch Colorectal cancer Group and TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg, 246: 693-701, 2007.
6. Swedish Rectal Cancer Trial: Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg, 162: 397-402, 1996.
7. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol, 23: 5644-5650, 2005.
8. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351: 1731-1740, 2004.
9. National Comprehensive Cancer Network practice guidelines in oncology (NCCN Guidelines), Rectal cancer, version 3. 2012. Available at http://www.nccn.org
10. Associazione Italiana di Oncologia Medica. Linee guida per i tumori del colon-retto. Dicembre 2010. Available at http://www.aiom.it
11. Tumori del colon-retto. Linee guida clinico organizzative per la regione Piemonte. Regione Piemonte Assessorato Sanità-Commissione Oncologica Regionale-Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte. Settembre 2001. vailable at http://www.cpo.it
12. Morris E, Howard RA, Gilthorpe MS, Craigs C, Forman D: The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshirés colorectal cancer patients. Br J Cancer, 95: 979-985, 2006.
13. Ruhstaller T, Roe H, Thurlimann B, Nicoll JJ: The multidisciplinary meeting: an indispensable aid to communication between different specialties. Eur J Cancer, 42: 2459-2466, 2006.
14. Paskeviciute B, Bölling T, Brinkmann M, Rudykina G, Ernst I, Stegger L, Schober O, Willich N, Weckesser M, Könemann S: Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Strahlenther Onkol, 185: 260-265, 2009.
15. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre randomized trial. Lancet, 373: 811-820, 2009.
16. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC; EORTC Radiotherapy Group Trial 22921: Chemotherapy with preoperative radiotherapy in rectal cancer; EORTC Radiotherapy Group Trial 22921. N Engl J Med, 355: 1114-1123, 2006.
17. Kachnic LA: Should preoperative or postoperative therapy be administered in the management of rectal cancer? Semin Oncol, 33: S64-S69, 2006.
18. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 331: 502-507, 1994.
19. Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB 3rd, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS: Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol, 24: 3542-3547, 2006.
20. Ramani VS, Sun Myint A, Montazeri A, Wong H: Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine. Colorectal Dis, 12 Suppl 2: 37-46, 2010.
21. Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti P, Bonetti A, Negru ME, Tronconi MC, Luppi G, Silvano G, Corsi DC, Bochicchio AM, Chiaulon G, Gallo M, Boni L: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol, 29: 2773-2780, 2011.
22. André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A: Improved overall survival with oxaliplatin, fluorouracil and leucovirin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol, 27: 3109-3116, 2009.
23. Bae SH, Park W, Choi DH, Nam H, Kang WK, Park YS, Park JO, Chun HK, Lee WY, Yun SH, Kim HC: Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiat Oncol, 6: 52, 2011.
24. Kleespies A, Füessl KE, Seeliger H, Eichhorn ME, Müller MH, Rentsch M, Thasler WE, Angele MK, Kreis ME, Jauch KW: Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis, 24: 1097-1099, 2009.
25. Brizel HE, Tepperman BS: Postoperative adjuvant irradiation for adenocarcinoma of the rectum and sigmoid. Am J Clin Oncol, 7: 679-685, 1984.
26. Mannaerts GH, Martijn H, Crommelin MA, Dries W, Repelaer van Driel OJ, Rutten HJ: Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IOERT in locally advanced primary rectal cancer. Int J Radiat Oncol Biol Phys, 47: 425-433, 2000.
27. Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, Garcia-Huttenlocher H, Bischof M, Weitz J, Harms W, Hensley FW, Buchler MW, Debus J, Krempien R: Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys, 67: 1381-1388, 2007.
28. Krengli M, Cannillo B, Turri L, Bagnasacco P, Berretta L, Ferrara T, Galliano M, Gribaudo S, Melano A, Munoz F, Sciacero P, Tseroni V, Bassi MC, Brambilla M, Inglese E: Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Technol Cancer Res Treat, 9: 393-398, 2010.
29. Kim TH, Chie EK, Kim DY, Park SY, Cho KH, Jung KH, Kim YH, Sohn DK, Jeong SY, Park JG: Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys, 62: 769-775, 2005.
30. Allal A, Bischoff S, Nouet P: Impact of the "belly-board" device on treatment reproducibility in preoperative radiotherapy. Strahlenther Onkol, 178: 259-262, 2001.
31. Drzymala M, Hawkins MA, Henrys AJ, Bedford J, Norman A, Tait DM: The effect of treatment position, prone or supine, on dose volume histograms for pelvic radiotherapy in patients with rectal cancer. Br J Radiol, 82: 321-327, 2009.
32. Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, Krishnan S, Das P: Intensity-modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol, 6: 63, 2011.
33. Arbea L, Ramos LI, Martínez-Monge R, Moreno M, Aristu J: Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol, 5: 17, 2010.
34. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L: Preoperative radiotherapy with or without concurrent fluorouracil and leucovirin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol, 24: 4620-4625, 2006.